Scientists at the University of Utah's Huntsman Cancer Institute analyzed the results of 14 studies by scientists all over the world associated with the International Headand NeckCancer ...
GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as ...
Some results have been hidden because they may be inaccessible to you